Cabozantinib: Mechanism of action, efficacy and indications

Cochin, V; Gross-Goupil, M; Ravaud, A; Godbert, Y; Le Moulec, S

Cochin, V (reprint author), Hop St Andre, Ctr Hosp Univ Bordeaux, 01 Rue Jean Burguet, F-33075 Bordeaux, France.

BULLETIN DU CANCER, 2017; 104 (5): 393

Abstract

Cabozantinib is an oral multiple tyrosine kinase receptor inhibitor (ITK): VEGFR2, c-MET and RET. Inhibition of VEGFR and c-MET decrease resistance of......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索